Clinical Trial Update: Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation trial evaluating birinapant with pembrolizumab in solid tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Birinapant
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Medivir | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-01-14